SAT1介导的巨噬细胞极化可能参与类风湿关节炎滑膜炎的机制研究

    The mechanism investigation of SAT1-mediated macrophage polarization during the pathogenesis of rheumatoid arthritis

    • 摘要:
      目的: 探究SAT1介导的巨噬细胞极化在类风湿关节炎(RA)发病机制中的作用。
      方法: 实验采用RAW264.7细胞,设置以下分组:对照组为正常培养的细胞;M1极化诱导组通过添加100 ng/mL LPS和20 ng/mL IFN-γ处理24 h;M2极化诱导组通过添加20 ng/mL IL-4处理24 h;LPS + IFN-γ + SAT1抑制剂组在添加LPS和IFN-γ的同时,加入SAT1抑制剂处理24 h;IL-4 + SAT1抑制剂组在添加IL-4的同时,加入SAT1抑制剂处理24 h。通过CCK-8法评估细胞活力;ELISA测定细胞因子分泌;实时定量PCR检测基因表达;运用Western blotting技术分析蛋白表达;通过免疫荧光染色识别巨噬细胞极化标志物;利用流式细胞术分析巨噬细胞表面标志物。
      结果: 与对照组相比,M1极化诱导组细胞存活率下降(P < 0.01),而M2极化诱导组细胞存活率变化无统计学意义(P > 0.05);LPS + IFN-γ + SAT1抑制剂组和IL-4 + SAT1抑制剂组细胞存活率均高于相应的极化诱导组,差异均有统计学意义(P < 0.05)。与对照组相比,M1极化诱导组中IL-1β、IL-6、TNF-α的OD值增加(P < 0.05),IL-10的OD值变化差异无统计学意义(P > 0.05);M2极化诱导组中IL-1β、IL-6、TNF-α的OD值降低,IL-10的OD值增加,差异均有统计学意义(P < 0.05)。相较于对照组,M1极化诱导组显示出iNOS和SAT1的mRNA表达水平增加,而Arg-1的mRNA表达水平则下降;相反,在M2极化诱导组中,Arg-1的mRNA表达水平提升,而iNOS和SAT1的mRNA表达水平则减少;进一步地,M1极化诱导组中iNOS、p-STAT6和SAT1蛋白的表达水平提高,Arg-1蛋白的表达水平降低;而在M2极化诱导组中,Arg-1蛋白的表达水平提高,iNOS、p-STAT6和SAT1蛋白的表达水平则降低,差异均有统计学意义(P < 0.05)。
      结论: SAT1抑制剂能够抑制与M1极化相关的基因和蛋白表达,同时促进M2极化相关基因和蛋白的表达,因此,SAT1可能成为治疗RA的潜在靶点。

       

      Abstract:
      Objective To explore the role of SAT1-mediated macrophage polarization in the pathogenesis of rheumatoid arthritis (RA).
      Methods The RAW264.7 cells were selected and divided into the following groups: the control group which consisted of normally cultured cells; the M1 polarization induction group: the cells were treated with 100 ng/mL LPS and 20 ng/mL IFN-γ for 24 h; the M2 polarization induction group: the cells were treated with 20 ng/mL IL-4 for 24 h; the LPS + IFN-γ + SAT1 inhibitor group: the cells were treated with the addition of SAT1 inhibitor while adding LPS and IFN-γ for 24 h; the IL-4 + SAT1 inhibitor group: the cells were treated with the addition of SAT1 inhibitor while adding IL-4 for 24 hs. The cell viability was assessed by the CCK-8 method; the cytokine secretion was determined by ELISA; the related gene expression was detected by Real-time PCR; and the related protein expression was analyzed by Western blot; the macrophage polarization markers were identified by immunofluorescence staining; the macrophage surface markers were analyzed by flow cytometry.
      Results Compared with the control group, the cell survival rate in the M1 polarization induction group was decreased significantly (P < 0.01), while no significant change in the M2 polarization induction group (P > 0.05); the cell survival rates in the LPS + IFN-γ + SAT1 inhibitor and IL-4 + SAT1 inhibitor groups were higher than those in the corresponding polarization induction groups (P < 0.05). Compared with the control group, the OD values of IL-1β, IL-6 and TNF-α in the M1 polarization induction group were increased significantly (P < 0.01), no significant change of IL-10 (P > 0.05); the OD values of IL-1β, IL-6, and TNF-α in the M2 polarization induction group were decreased significantly (P < 0.05), and the OD value of IL-10 was increased significantly (P < 0.05). Compared with the control group, the mRNA expression levels of iNOS and SAT1 in the M1 polarization induction group were increased significantly (P < 0.01), and the Arg-1 mRNA expression level was decreased (P < 0.05); the Arg-1 mRNA expression level in the M2 polarization induction group was increased significantly (P < 0.01), and the mRNA expression levels of iNOS and SAT1 were decreased significantly (P < 0.05). Compared with the control group, the protein expression levels of iNOS, p-STAT6, and SAT1 in the M1 polarization induction group were increased significantly (P < 0.01), and the Arg-1 protein expression level was decreased significantly (P < 0.01); the Arg-1 protein expression level in the M2 polarization induction group was increased significantly (P < 0.01), and the expression levels of iNOS, p-STAT6, and SAT1 proteins were decreased significantly (P < 0.05).
      Conclusions The SAT1 inhibitor can inhibit the expression of M1 polarization-related genes and proteins, and promote the expression of M2 polarization-related genes and proteins. Therefore, SAT1 may become a potential target for the treatment of RA.

       

    /

    返回文章
    返回